Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

GANXGANX
Showing 7 of 15 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in GAIN THERAPEUTICS INC

Yes. Susquehanna International Group holds 78,206 shares of GANX (Gain Therapeutics), worth $158,758, as of its Q2 2026 13F filing. It reduced the position by 353,061 shares (-81.9%) from Q1 2026. Susquehanna International Group has held GANX since Q4 2024, across 7 quarterly 13F filings.

Current Value

$158,758

Current Shares

78,206

Total Value Change

+$57,426

Total Shares Change

+31,293

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
78,206
-81.9%
$158,7580.0%$2.03
0
2026-Q1
Decreased
431,267
-37.0%
$836,6580.0%$2.63
0
2025-Q4
Increased
684,349
+750.8%
$2.2M0.0%$3.05
42
2025-Q3
Increased
80,435
+1.1%
$142,3700.0%$1.81
15
2025-Q2
Decreased
79,551
-7.5%
$143,1920.0%$1.97
0
2025-Q1
Increased
85,958
+83.2%
$164,1800.0%$1.89
24
2024-Q4
New
46,913
-
$101,3320.0%$2.18
33

Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used